Journal Guide

Expert Opinion on Therapeutic Targets ranks #53 of 249 in the Pharmacology & Pharmacy category in the 2010 ISI Journal Citation Reports.Expert Opinion on Therapeutic Targets (ISSN 1472-8222 [print], 1744-7631 [electronic]) is a MEDLINE-indexed, peer-reviewed, international journal publishing review articles and original papers on recently identified novel molecular drug targets, providing expert opinion on the scope for future development and impact on drug discovery.The Editors welcome: * Reviews covering novel disease targets at the molecular level and their implications on future drug development * Original research papers reporting results of target selection and validation studies and basic mechanism of action studies for investigative and marketed drugsThe audience consists of scientists, managers and decision makers in the pharmaceutical industry, and others closely involved in R&D.Read More: http://informahealthcare.com/page/Description?journalCode=ett.

Expert Review of Molecular Diagnostics publishes expert reviews of the latest advancements in the field of molecular diagnostics including the detection and monitoring of the molecular causes of disease that are being translated into groundbreaking diagnostic technologies to be used in the clinical diagnostic setting. Each issue of Expert Review of Molecular Diagnostics contains leading reviews on current and emerging topics relating to molecular diagnostics, subject to a rigorous peer review process; cutting-edge editorials discussing contentious issues in the field; diagnostic profiles featuring independent, expert evaluations of diagnostic tests; meeting reports of recent molecular diagnostics conferences and key paper evaluations reviewing significant, recently published articles carefully selected and assessed by specialists in molecular diagnostic therapy.

Expert Review of Precision Medicine and Drug Development publishes original research and review articles covering the development and clinical application of medicine to be used in a personalized therapy setting. In an era where medicine is recognizing that a one-size-fits-all approach is not always appropriate, it has become necessary to identify patients responsive to treatments and treat patient populations using a tailored approach. Areas covered include:

• Development and application of drugs targeted to specific genotypes and populations, as well as advanced diagnostic technologies and significant biomarkers that aid in this. 
• Clinical trials and case studies within personalized therapy and drug development. 
• Screening, prediction and prevention of disease, prediction of adverse events, treatment monitoring, effects of metabolomics and microbiomics on treatment.
• Secondary population research, genome-wide association studies, disease–gene association studies, personal genome technologies. 
• Ethical and cost–benefit issues, the impact to healthcare and business infrastructure, and regulatory issues.

Expert Review of Vaccines (ISSN 1476-0584) provides expert reviews on the clinical effectiveness of new vaccines. Coverage includes vaccine technology, vaccine adjuvants, prophylactic vaccines, therapeutic vaccines, AIDS vaccines and vaccines in bioterrorism. All articles are subject to rigorous peer-review.

Extremophiles features original research articles, reviews, and method papers on the biology, molecular biology, structure, function, and applications of microbial life at the edges of survivability. Conditions covered include high or low temperature, pressure, acidity, alkalinity, salinity, or desiccation; or in the presence of organic solvents, heavy metals, normally toxic substances, or radiation.The coverage incorporates aspects of multiple disciplines, including molecular biology, biodiversity, genetics, genomics, metagenomics, proteomics, bioinformatics, survival strategies, macromolecular structure, development, biotechnology, fermentation technology, ultrastructure, biotransformation, metabolism, enzymology, biomembranes, bioenergetics, physiology, cell biology, symbiosis, ecology, bioremediation, methodologies, evolution, phylogeny, taxonomy, astrobiology, and others.Color figures are free in print and online.

Future Cardiology reflects a new era of cardiology and highlights the new molecular approach to advancing cardiovascular therapy. Coverage also reflects the major technological advances in bioengineering in cardiology in terms of advanced and robust devices, miniaturization, imaging, system modeling and information management issues. We also take a new approach to the way information is structured and delivered, so that its value is maximized to the reader. Future Cardiology provides a forward-looking, authoritative perspective with a readily accessible format to inform future clinical practice in cardiovascular care. Integrated molecular approaches will have a great impact on cardiovascular healthcare in the future. However, the expense of such treatments viewed alongside the increasingly aging population will require a fundamental review of how this care is provided, and exploration of their relevance in the clinical setting, to inform future clinical practice in cardiovascular care.

Medicinal chemistry has evolved rapidly into a highly interdisciplinary field, enriched by the collaborative efforts of experts from a wide spectrum of specialist areas, from chemoinformaticians and physical chemists to molecular biologists and pharmacologists. Future Medicinal Chemistry provides a monthly point of access to commentary and debate for this ever-expanding and diversifying community. The journal showcases milestones in pharmaceutical R&D and features expert analysis of emerging research, from the identification of targets, through to the discovery, design, synthesis and evaluation of bioactive agents.

Gene Therapy covers both the research and clinical applications of the new genetic therapy techniques currently being developed. Over the last decade, gene therapy protocols have entered clinical trials in increasing numbers and as they cover a wide spectrum of diseases, these studies promise to unite the diverse organ-based specialities into which modern medicine has become divided. Gene Therapy covers all aspects of gene therapy as applied to human disease, including: * novel technological developments for gene transfer, control and silencing * basic science studies of mechanisms of gene transfer and control of expression * preclinical animal model systems and validation studies * clinical trial reports which have significant impact for the field * gene-based vaccine development and applications * cell-based therapies including all aspects of stem cells and genetically modified cellular approaches.

Medicine in the post-genomic era. Genome Medicine is an online peer-reviewed journal which publishes open access research articles of outstanding quality in all areas of medicine studied from a genomic or post-genomic perspective. The journal has a special focus on the latest technologies and findings that have an impact on the understanding and management of human health and disease.

Other key features include a continuously updated directory of human gene marker and gene therapy clinical protocols, as well as ethical/legal/regulatory papers related directly to the area of gene transfer into humans.

Infectious Disorders - Drug Targets aims to cover all the latest and outstanding developments in medicinal chemistry, pharmacology, molecular biology, genomics and biochemistry of contemporary molecular targets involved in infectious disorders e.g. disease specific proteins, receptors, enzymes, genes. Each issue of the journal contains a series of timely in-depth reviews and research articles written by leaders in the field covering a range of current topics on drug targets involved in infectious disorders. As the discovery, identification, characterization and validation of novel human drug targets for anti-infective drug discovery continue to grow, this journal will be essential reading for all pharmaceutical scientists involved in drug design, discovery and development.

The International Journal of Peptide Research and Therapeutics publishes the latest developments in peptide therapeutics and high quality research covering all aspects of peptide science. The journal brings together in a single source the most exciting peer-reviewed work in peptide research, including isolation, structural characterization, synthesis and biological activity of peptides, and thereby aids in the development of unifying concepts from diverse perspectives.Coverage includes new advances in peptide drug delivery systems; application of peptide therapeutics to specific diseases; advances in synthetic methods; development of new procedures for construction of peptide libraries and methodology for screening of such mixtures; the use of peptides in the study of enzyme specificity and mechanism, receptor binding and antibody/antigen interactions; applications of such techniques as chromatography, electrophoresis, NMR and X-ray crystallography, mass spectrometry.IJPRT requests that all authors comply to

Journal for ImmunoTherapy of Cancer is an open access, peer reviewed journal that encompasses all aspects of tumor immunology and cancer immunotherapy, from basic research through to clinical applications.The journal welcomes submissions in the following areas and other related topics:Basic Tumor ImmunologyTumor antigens, innate and adaptive anti-tumor immune mechanisms, immune regulation, immune response, cancer and inflammation, preclinical models, chemotherapy and radiotherapy interactions with the anti-tumor immune responseClinical/Translational Cancer ImmunotherapyFirst-in-man clinical trials, phase II/III clinical studies, immune monitoring investigations, tumor microenvironment, host genetics and clinical outcomeImmunotherapy BiomarkersPredictive/prognostic biomarker studies, gene expression studies in cancer immunotherapy, serological immune biomarkers, multiparameter flow cytometry-defined immune biomarkers, high content immunohistological studiesReviews/EditorialsTriggering discussion on hot topics and innovative concepts

Journal for ImmunoTherapy of Cancer is the official journal of the Society for Immunotherapy of Cancer (SITC). The Society for Immunotherapy of Cancer (SITC) is a 501 (c)(3) non-profit society of medical professionals that was established in 1984 to exchange, encourage and promote information about the promise and breakthroughs of biological therapies, including immunotherapy, for patients with cancer. SITC is the world's leading member society of medical professionals dedicated to advancing cancer immunotherapy through its initiatives, educational sessions, and collaborative endeavors. The society has become THE forum for innovative discussions in the field.

The Journal of Asian Natural Products Research (JANPR) publishes chemical and pharmaceutical studies in the English language in the field of natural product research on Asian ethnic medicine. The journal publishes work from scientists in Asian countries, e.g. China, Japan, Korea and India, including contributions from other countries concerning natural products of Asia. The journal is chemistry-orientated. Major fields covered are: isolation and structural elucidation of natural constituents (including those for non-medical uses), synthesis and transformation (including biosynthesis and biotransformation) of natural products, pharmacognosy, and allied topics. Biological evaluation of crude extracts are acceptable only as supporting data for pure isolates with well-characterized structures.All published research articles in this journal have undergone rigorous peer review, based on initial editor screening and anonymized refereeing by at least two expert referees. STARTaylor & Francis/Routledge are committed to the widest possible dissemination of its journals to non-profit institutions in developing countries. Our STAR initiative offers individual researchers in Africa, South Asia and many parts of South East Asia the opportunity to gain one month's free online access to 1,300 Taylor & Francis journals. For more information, please visit the STAR website. DisclaimerTaylor & Francis makes every effort to ensure the accuracy of all the information (the "Content") contained in its publications. However, Taylor & Francis and its agents and licensors make no representations or warranties whatsoever as to the accuracy, completeness or suitability for any purpose of the Content and disclaim all such representations and warranties whether express or implied to the maximum extent permitted by law. Any views expressed in this publication are the views of the authors and are not the views of Taylor & Francis.

The Journal of Biochemical and Molecular Toxicology is an international journal that contains original research papers, rapid communications, mini-reviews, and book reviews, all focusing on the molecular mechanisms of action and detoxication of exogenous and endogenous chemicals and toxic agents. The scope includes effects on the organism at all stages of development, on organ systems, tissues, and cells as well as on enzymes, receptors, hormones, and genes. The biochemical and molecular aspects of uptake, transport, storage, excretion, lactivation and detoxication of drugs, agricultural, industrial and environmental chemicals, natural products and food additives are all subjects suitable for publication. Of particular interest are aspects of molecular biology related to biochemical toxicology. These include studies of the expression of genes related to detoxication and activation enzymes, toxicants with modes of action involving effects on nucleic acids, gene expression and protein synthesis, and the toxicity of products derived from biotechnology. Given the rapid development of the field of toxicology during the last few decades and the fundamental importance of biochemical mechanisms in all aspects of toxicology the Journal of Biochemical and Molecular Toxicology is of interest, not only to active investigators in the field but to many other scientists. These include other biochemists, molecular biologists, and toxicologists involved in industrial and contract research and testing laboratories, and those involved in legal and regulatory work related to toxic chemicals. The Journal of Biochemical and Molecular Toxicology is published bimonthly with one volume of 6 issues per calendar year.

Journal of Biological Sciences is a peer-reviewed and well indexed scientific journal dedicated to publish and disseminate the high quality scientific research work in the broad field of biological sciences. Scope of the journal includes: cell biology, developmental biology, structural biology, microbiology, molecular biology & genetics, biochemistry, biotechnology, biodiversity, ecology, marine biology, plant biology, and bioinformatics.

The Journal of Biomolecular Screening (JBS) is the leading peer-reviewed journal focusing on drug discovery sciences. JBS publishes information that enables researchers to evaluate current technologies and incorporate applications to enhance performance and objectives. Manuscripts and editorial commentary emphasize scientific and technical applications and advances in target identification/validation; lab automation and robotics; high-throughput screening (HTS); lead generation/optimization; virtual screening, chemoinformatics; diagnostic assays; assay development; assay technologies (novel applications, comparisons); data/image analysis, statistics and information technologies/methods; high content screening, imaging platforms; sample management (library design, compound logistics, chemical diversity); biological reagent production, characterization and management for drug discovery (cell lines, stem cells, surrogate tissues/species [xenopus, zebrafish, yeast]); genomic, proteomic screening; biomarkers; high throughput approaches to PK, ADME and predictive toxicology; legal, licensing issues.This publication will be of particular interest to those involved in analytical chemistry, applied microbiology, automation, biochemistry, bioengineering, biomedical optics, biotechnology, bioinformatics, cell biology, DNA science and technology, genetics, information technology, medicinal chemistry, molecular biology, natural products chemistry, organic chemistry, pharmacology, spectroscopy, and toxicology.